Oral Solid Dosage (OSD) is the inspection and evaluation of the manufacturing and control processes used to manufacture solid oral dosage form pharmaceutical products.
Join the Conversation
As an ISPE member you can engage with 22 active CoPs, including new communities focused on Artificial Intelligence and Sustainability. Connect with experts and join the conversations: Become an ISPE member
ISPE members: Get more involved by volunteering.
Guidance Documents
Advanced Manufacturing (1)
Manufacturing Operations (3)
Microbiological & Viral Contamination Control (1)
Oral Solid Dosage (3)
Process Analytical Technology (1)
Community Discussions
Community Discussions
Nov 06, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Oct 31, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Oct 20, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Oct 18, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Oct 16, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Jul 17, 2025
Manufacturing Operations
Oral Solid Dosage
Pharmaceutical Engineering Magazine Articles
White Papers
November / December 2025
In This Issue: We dive into sustainable practices in the pharma industry and effective ways to…
September / October 2025
As regulatory trends and quality initiatives continue to evolve in the pharmaceutical industry, this…
July / August 2025
The AI Paradox Cover: The increasing digitalization of the pharmaceutical and medical device…
May / June 2025
The ATMP Issue: In this issue, we focus on the manufacturing of advanced therapy medicinal products…
March / April 2025
A Skill Management Framework for a Pharma 4.0™ Workforce Feature: Pharma 4.0™ is driving fundamental…
iSpeak Blog Posts
Videos
Professional Development Training
ICH Q6A: Specifications, Test Procedures, and Acceptance Criteria for New Drug Substances and Products
Delivery Mode: Webinar This course covers testing and quality control requirements in marketing authorization/new drug applications, emphasizing ICH guidelines. It focuses on ICH Q6A, detailing test procedures and acceptance criteria for new drug substances/products to ensure global consistency and safety. The course also integrates later guidelines (ICH Q8, Q9, Q10, Q11), introducing science and risk-based approaches. Participants will learn to navigate global marketing authorization/new drug applications, contributing to high-quality pharmaceutical product development. CEUs are provided once…
GMP Sterile Pharmaceutical Manufacturing Facility Training Course
This course uses the second edition of the ISPE Baseline® Guide: Sterile Product Manufacturing Facilities and the FDA's Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing - Current Good Manufacturing Practice to provide an understanding of the key requirements and GMPs for sterile manufacturing facilities.
White Papers
November / December 2025
In This Issue: We dive into sustainable practices in the pharma industry and effective ways to…
September / October 2025
As regulatory trends and quality initiatives continue to evolve in the pharmaceutical industry, this…
July / August 2025
The AI Paradox Cover: The increasing digitalization of the pharmaceutical and medical device…